CoChat

Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients

Ludidi, S., Jonkers, D. M., Koning, C. J., Kruimel, J. W., Mulder, L., van der Vaart, I. B., Conchillo, J. M., Masclee, A. A. M. · 2014 · Neurogastroenterology & Motility
Cited by 49

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background: Irritable bowel syndrome ( IBS ) is characterized by heterogeneous pathophysiology and low response to treatment. Up to 60% of IBS patients suffers from visceral hypersensitivity, which is associated with symptom severity and underlying pathophysiological mechanisms. Recently, positive effects of probiotics in IBS have been reported, but overall the response was modest. We performed a study in IBS patients, characterized by visceral hypersensitivity measured with the rectal barostat, aiming to assess the effect of 6 weeks of multispecies probiotic mix on visceral pain perception. Methods: We conducted a randomized, placebo‐controlled, double‐blind trial in forty Rome III IBS patients with visceral hypersensitivity. Prior to intake, patients kept a 2‐week symptom diary and underwent a rectal barostat measurement. When hypersensitivity was confirmed, participation was allowed and patients received a multispecies probiotic with in vitro proven potential beneficial effects on mechanisms contributing to visceral hypersensitivity (six different probiotic strains; 10 9 cfu/g), or a placebo product of one sachet (5 g) per day for 6 weeks. At the end of the intervention period, visceroperception and symptoms were reassessed. Key Results: Thirty‐five patients completed the trial. The percentage of patients with visceral hypersensitivity decreased significantly in the probiotic and placebo group (76.5% and 71.4%, respectively; N.S . between groups). Improvement in pain scores and mean symptom score did not differ between the probiotic and placebo group. Conclusions & Inferences: In this placebo‐controlled trial in IBS patients with visceral hypersensitivity, no significant effect of a multispecies probiotic on viscerperception was observed. The study has been registered in the US N ational L ibrary of M edicine ( http://www.clinicaltrials.gov , NCT00702026 ).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nmo.12320

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 49

Metadata

Authors
Ludidi, S., Jonkers, D. M., Koning, C. J., Kruimel, J. W., Mulder, L., van der Vaart, I. B., Conchillo, J. M., & Masclee, A. A. M.
Venue
Neurogastroenterology & Motility
Publisher
Wiley
Published
2014-03-04
Volume
26
Issue
5
Pages
705-714
ISSN
  • 1350-1925 (ISSN-L)
  • 1365-2982
OpenAlex
W2105464891
Cited by
49
References
19
FWCI
4.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. https://app.cochat.ai/papers/10.1111/nmo.12320
The paper
Ludidi, S., Jonkers, D. M., Koning, C. J., Kruimel, J. W., Mulder, L., van der Vaart, I. B., Conchillo, J. M., & Masclee, A. A. M. (2014). Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.12320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.